KALV Form 144: Notice to Sell 33,800 Shares

KALV submitted a Form 144 notice to sell 33,800 shares of Common Stock on 05/27/2026.

Rhea-AI Filing Summary

KALV submitted a Form 144 notice to sell 33,800 shares of Common Stock on 05/27/2026. The filing lists the planned sale as a Stock Option Exercise with cash proceeds. The excerpt also shows recent open-market sales by Christopher M. Yea of 1,966; 2,358; and 1,108 shares on May 26, May 22, and May 18, 2026 respectively.

Key Figures

Shares to be sold: 33,800 shares Aggregate consideration listed: $905,224.84 Sale on 05/26/2026: 1,966 shares +2 more

5 metrics

Shares to be sold 33,800 shares planned sale dated 05/27/2026

Aggregate consideration listed $905,224.84 value shown adjacent to the 33,800-share entry

Sale on 05/26/2026 1,966 shares past sale by Christopher M. Yea on 05/26/2026 for $52,645.15

Sale on 05/22/2026 2,358 shares past sale by Christopher M. Yea on 05/22/2026 for $63,157.62

Sale on 05/18/2026 1,108 shares past sale by Christopher M. Yea on 05/18/2026 for $29,650.08

Key Terms

Form 144, Stock Option Exercise, Aggregate consideration

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 05/27/2026 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Aggregate consideration financial

"33800 | 905224.84 | 53240888"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KALV's Form 144 disclose about the planned sale?

The Form 144 discloses a planned sale of 33,800 shares of Common Stock on 05/27/2026. The filing identifies the method as a Stock Option Exercise and lists the transaction as to be settled for cash.

Who sold shares in the past three months according to the excerpt?

Christopher M. Yea sold shares on 05/26/2026, 05/22/2026, and 05/18/2026. The filing lists sales of 1,966, 2,358, and 1,108 shares on those dates respectively.

What aggregate proceeds are shown in the excerpt for the planned sale?

The excerpt includes a numeric value of $905,224.84 adjacent to the 33,800-share line. The filing pairs that dollar figure with the 33,800 share entry in the securities table.

What settlement method is indicated for the 33,800-share transaction?

The filing indicates the 33,800-share transaction arises from a Stock Option Exercise and is to be settled for cash on 05/27/2026. No further proceeds allocation is shown in the excerpt.

On which exchange is the security listed as shown in the excerpt?

The securities row in the excerpt lists NASDAQ as the exchange for the Common Stock. The filing associates the 33,800-share entry with the NASDAQ listing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 05:18 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001691102
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KalVista Pharmaceuticals, Inc.
SEC File Number	001-36830
Address of Issuer	200 Crossing Boulevard Framingham MASSACHUSETTS 01702
Phone	857-999-0075
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER M YEA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	33800	905224.84	53240888	05/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/27/2026	Stock Option Exercise	Issuer			33800	05/27/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER M YEA 55 Cambridge Parkway Cambridge MA 02142	Common	05/26/2026	1966	52645.15
CHRISTOPHER M YEA 55 Cambridge Parkway Cambridge MA 02142	Common	05/22/2026	2358	63157.62
CHRISTOPHER M YEA 55 Cambridge Parkway Cambridge MA 02142	Common	05/18/2026	1108	29650.08

144: Remarks and Signature

Remarks
Date of Notice	05/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Martyn Yea
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)